applications in research and therapy
Semaglutide can activate your brains GLP-1 receptors, reducing the feeling of hunger and helping you decrease food intake
It is critical to consult a healthcare professional to understand the benefits and risks of starting a GLP-1 agonist and determine if it fits you
Consequently, the definition of treatment success is also expanding beyond headline weight loss achieved, to include the full spectrum of patients therapeutic needs, for example: Effective and durable weight maintenance Managing co-morbidities along the cardio-metabolic-renal spectrum Preserving muscle mass Tolerability, safety Convenience, e.g., delivered via oral therapies and/or less-frequent dosing * Including diabetes, ASCVD, Afib, HTN, PAH, dyslipidaemia, heart failure, PAD, MI, stroke, cardiovascular disease, CKD Source: IQVIA LAAD